SCHEMBL16490263

SCHEMBL16490263

CCN(CC)c1ccc2c(c1)Oc1cc(C)ccc1C2c1ccc(S(=O)(=O)O)cc1S(=O)(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
CNR2 P34972 10/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
BRCA1 P38398 1/20 0.37
HTT P42858 1/20 0.37
CASP7 P55210 1/20 0.37
HBB P68871 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699608 0.94 MEN1 (0.40) MEN1KMT2AL3MBTL1PKMMAPK1
SCHEMBL6403066 0.84 MEN1 (0.35) MEN1KMT2AL3MBTL1PKMMAPK1
SCHEMBL3844704 0.83 CNR2 (0.38) MEN1KMT2AL3MBTL1CNR2CYP2C9
SCHEMBL17264739 0.83 MEN1 (0.33) MEN1KMT2AL3MBTL1CYP2C9CYP2C19
SCHEMBL3839170 0.82 MEN1 (0.36) MEN1KMT2AL3MBTL1PKMMAPK1
SCHEMBL3839806 0.82 KMT2A (0.37) MEN1KMT2AL3MBTL1CNR2CYP2C9
SCHEMBL3840387 0.82 HTT (0.41) MEN1KMT2APKMMAPK1CYP2C9
SCHEMBL3843291 0.81 CA12 (0.37) MEN1KMT2APKMCYP2C9CYP2C19
SCHEMBL19293385 0.78 KMT2A (0.38) MEN1KMT2AL3MBTL1CYP2C9CYP2C19
SCHEMBL17626410 0.76 MEN1 (0.34) MEN1KMT2ACYP2C9CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364403-B2 Hair treatment methods PERACHEM LIMITED (GB) 2016-06-14 US disclosed
US-9320695-B2 Hair treatment methods PERACHEM LIMITED (GB) 2016-04-26 US disclosed
US-20150068548-A1 Hair Treatment Methods HSNF LIMITED (GB) 2015-03-12 US disclosed
US-20150047131-A1 Hair Treatment Methods HSNF LIMITED (GB) 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150068548-A1 Hair Treatment Methods TST, OAT, SLC14A1 MEN1 3002/4885KMT2A 2377/4885L3MBTL1 3454/4885
US-20150047131-A1 Hair Treatment Methods POLR1C, SHH, DNMT3A MEN1 2294/4885KMT2A 372/4885L3MBTL1 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.